Goodwill and Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2025

Goodwill and Intangible Assets Disclosure [Abstract]

Summary of Intangible Assets, Net

As of March 31, 2025, the Company’s intangible assets, net consists of the following:

(in thousands)	Weighted average amortization period	Gross carrying amount		Accumulated amortization		Net carrying amount
Intangible assets
Amortizing intangible assets:
Payor contracts	13 years	$	22,191	$	(12,564)	$	9,627
Trade names	10 years	6,650		(3,410)		3,240
Clinical contracts and noncompete agreements	8 years	3,191		(2,022)		1,169
Total intangible assets		$	32,032	$	(17,996)	$	14,036

As of December 31, 2024, the Company’s intangible assets, net consists of the following:

(in thousands)	Weighted average amortization period	Gross carrying amount		Accumulated amortization		Net carrying amount
Intangible assets
Amortizing intangible assets:
Payor contracts	13 years	$	22,191	$	(12,054)	$	10,137
Trade names	10 years	6,650		(3,247)		3,403
Clinical contracts and noncompete agreements	8 years	3,191		(1,921)		1,270
Total intangible assets		$	32,032	$	(17,222)	$	14,810

Summary of Estimated Aggregate Amortization Expense

The estimated aggregate amortization expense for each of the five succeeding fiscal years as of March 31, 2025 is as follows:

(in thousands)	Amount
Year ending December 31:
2025 (remaining nine months)	$	2,317
2026	3,060
2027	2,933
2028	2,828
2029	463
Thereafter	2,435
Total	$	14,036

Summary of Goodwill and Changes in the Carrying Amount of Goodwill

The goodwill allocated to each of the reporting units as of March 31, 2025 and December 31, 2024 is as follows:

(in thousands)	March 31, 2025		December 31, 2024
Patient services	$	2,679	$	2,679
Dispensary	4,551		4,551
Clinical trials & other	—		—
Total goodwill	$	7,230	$	7,230